Coenzyme Q10 is one of 528 small molecule programs targeting Charcot-Marie-Tooth disease. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2829 competitors in Breast Cancer
Coenzyme Q10
DATROWAY
Megace
Zolymbus
Methylthioninium Chloride
MS Contin
Effexor
Recentin
Chirocaine
Acupan
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details